Mycobacterial Disease
Inhaled IFN-gamma effectively treats non-TB mycobacterial pulmonary disease
Published in TB and Outbreaks Week, November 30th, 2004
According to scientists in the United States, "Pulmonary infection with nontuberculous mycobacteria (NTM) in previously healthy human immunodeficiency virus-seronegative individuals is difficult to treat.
"Recently, functional interferon (IFN)-gamma deficiency has been identified in individuals susceptible to this disease. Treatment with inhaled (IFN)-gamma for NTM pulmonary disease associated with functional IFN-gamma deficiency has not been previously described."
"In this study," said T.S. Hallstrand and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Bacterial Resistance
Indian Salmonella Typhi isolates have reduced ciprofloxacin susceptibility - HIV/AIDS & Tuberculosis
HIV has less effect on point prevalence of TB disease than on TB incidence - Meningococcal Epidemiology
New genetic lineages of Neisseria meningitides W135 continue to emerge - Tuberculosis
Genetic susceptibility to tuberculosis in Africans is polygenic - Tuberculosis
Serum IgE levels higher in tuberculosis patients coinfected with HIV/parasites - Anthrax
Company gets $877.5 million U.S. government contract to supply anthrax vaccine - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
